Baseline-derived neutrophil-to-lymphocyte ratio (dNLR) and lactate dehydrogenase (LDH) to predict the benefit of immune checkpoint inhibitors (ICI) in advanced non-small cell lung cancer (NSCLC) patients.

Affiliation auteurs!!!! Error affiliation !!!!
TitreBaseline-derived neutrophil-to-lymphocyte ratio (dNLR) and lactate dehydrogenase (LDH) to predict the benefit of immune checkpoint inhibitors (ICI) in advanced non-small cell lung cancer (NSCLC) patients.
Type de publicationJournal Article
Year of Publication2017
AuteursMezquita L, Auclin E, Ferrara R, Audigier-Valette C, Tessonnier L, Charrier M, Boucher MEve, Lahmar J, Caramella C, Remon J, Planchard D, Adam J, Gazzah A, Chaput N, Soria J-C, Besse B
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume35
Date PublishedMAY 20
Type of ArticleMeeting Abstract
ISSN0732-183X
DOI10.1200/JCO.2017.35.15_suppl.9089